Excessive cell proliferation in the VHL-dependent RCC cells was rescued by treatment with alisertib, an AURKA−specific chemical inhibitor (244), however, ciliary integrity in the treated RCC cells was not investigated. This evidence concerns the gene VHL and renal cell carcinoma.